The new chilled water facility marks the completion of the first phase of the multi-year sustainability initiative.
Vous n'êtes pas connecté
MindBio Therapeutics (CSE:MBIO) announces the successful completion of its Phase 1 and 2a clinical trials on depression treatment.
The new chilled water facility marks the completion of the first phase of the multi-year sustainability initiative.
Beach Energy has announced first gas from the Thylacine West 1 and 2 development wells following successful connection to the Otway Gas Plant. First...
On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December...
HAMPTON, N.J., Oct. 26, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today positive results from the Company’s...
Results provide first evidence of biological and clinical effect of a mid-domain tau-targeting disease-modifying therapy1 In full study population...
Sheriff General Hospital has announced the successful completion of its first-ever brain surgery, and according to a release from the institution, it...
Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The...
Cancer Research UK, one of the world's largest funders of cancer research, and KisoJi Biotechnology Inc., a company focussed on the discovery and...